Alexandria Hammond

Stock Analyst at B of A Securities

(3.83)
# 698
Out of 5,044 analysts
17
Total ratings
66.67%
Success rate
8.99%
Average return

Stocks Rated by Alexandria Hammond

89bio
Aug 25, 2025
Maintains: Buy
Price Target: $30$29
Current: $14.84
Upside: +95.42%
Akero Therapeutics
May 27, 2025
Maintains: Buy
Price Target: $63$64
Current: $54.00
Upside: +18.52%
Regeneron Pharmaceuticals
Nov 15, 2024
Initiates: Outperform
Price Target: $1,150
Current: $652.91
Upside: +76.13%
Pfizer
Nov 15, 2024
Initiates: Underperform
Price Target: $25
Current: $24.29
Upside: +2.92%
Moderna
Nov 15, 2024
Initiates: Underperform
Price Target: $40
Current: $24.70
Upside: +61.94%
Merck & Co.
Nov 15, 2024
Initiates: Peer Perform
Price Target: n/a
Current: $86.58
Upside: -
Eli Lilly and Company
Nov 15, 2024
Initiates: Outperform
Price Target: $1,000
Current: $813.53
Upside: +22.92%
Johnson & Johnson
Nov 15, 2024
Initiates: Outperform
Price Target: $190
Current: $186.60
Upside: +1.82%
Gilead Sciences
Nov 15, 2024
Initiates: Outperform
Price Target: $110
Current: $118.50
Upside: -7.17%
Bristol-Myers Squibb Company
Nov 15, 2024
Initiates: Peer Perform
Price Target: n/a
Current: $42.60
Upside: -
Initiates: Peer Perform
Price Target: n/a
Current: $147.86
Upside: -
Initiates: Outperform
Price Target: $205
Current: $225.14
Upside: -8.95%
Initiates: Underperform
Price Target: $150
Current: $421.60
Upside: -64.42%